"PDA is committed to providing science-based commentary on the quality metrics draft guidance, as we did with the release of the first draft in 2015," said Richard Johnson, PDA president. "The quality metrics/culture conference will be the fourth held by PDA on this important topic since the U.S. FDA called on industry participation in 2013."
More information on the conference is available here. Press passes for members of the press can be requested using PDA's online form.
PDA's comments on the first draft of the quality metrics guidance are available here.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
Media Inquiries: Walt Morris, 301-656-5900, x. 148; email@example.com
Logo - http://photos.prnewswire.com/prnh/20130226/DC66667LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pda-quality-metrics-task-force-to-comment-on-us-fda-metrics-draft-guidance-300370877.html
SOURCE Parenteral Drug Association